News & Analysis

Colossal to genetically re-create Woolly Mammoths to combat climate change

14 Sep 2021 | by: Kirsteen Mackay

Colossal to genetically re-create Woolly Mammoths to combat climate change

Private Biotech firm Colossal wants to genetically re-create woolly mammoths to re-wild the arctic. It hopes to birth these hybrid creatures within six years in a bid to combat climate change. This highly controversial plan has attracted $15m and a slew of important names, including Silicon Valley venture capitalists and renowned life coach Tony Robbins.

Colossal was co-founded by entrepreneur and former CEO of Hypergiant Ben Lamm and well-respected geneticist George Church.

Its innovative plan is to use CRISPR gene editing to edit the genome of existing Asian elephants. Colossal plans to bring back the mammoth, restore the natural ecosystem, and fight climate change.

Colossal co-founder Ben Lamm noted:

“Our goal is not to just bring back the Mammoth, that’s a feat in itself. It’s for the successful re-wilding of mammoths. If you take that toolkit, you have all the tools are your disposal to prevent extinction or to bring back critically endangered species.”

Mammoth in the middle of mountains . This is a 3d render illustration
Mammoth in the middle of mountains . This is a 3d render illustration

$15m seed funding round

On September 13, Colossal launched with a $15m funding round led by Thomas Tull.

Tull is the former CEO of Legendary Entertainment which brought cinematic hits like Jurassic World, Dune, and The Dark Knight to our screens.

Other notable investors in the round include Animal Capital, At One Ventures, Bold Capital, Breyer Capital, Capital Factory, Climate Capital, Draper Associates, Global Space Ventures, Jazz Ventures, Jeff Wilke, Liquid2 Ventures, Tony Robbins, and First Light Capital., Winklevoss Capital.

Co-founder Church is famous for creating the world’s first direct genomic sequencing method in the eighties. He also helped start the Human genome project. Then, in 2015, along with his colleagues, he edited 62 genes in pig embryos to attempt to grow organs for human transplants.

His woolly mammoth recreation has been in the pipeline for several years. Back in 2017, he’d already begun heading in this direction when his Harvard lab announced it had added 45 genes to the genome of an Asian elephant.

Church’s lab had already attracted a $100,000 donation from Peter Thiel.

The $15m is expected to go towards birthing live mammoth calves within the next four to six years.

Many hurdles to cross

The effects would be staggering if this project can cross the myriad of ethical hurdles it faces and rewild the arctic with woolly mammoths. It would not only have proven the ability to resurrect dead creatures, but they could also perform ‘genetic rescue’ – preventing extinction from ever happening.

It’s believed around a million plants and animals currently face extinction, so this would be groundbreaking.

As exciting and futuristic the story is, there are many reasons to fear bringing long-dead species back. The world is different now; they may spread disease, displace existing species, and even exacerbate climate change problems.

Ben Lamm doesn’t really worry. He sees money-spinning potential in the process, with or without birthing mammoths:

“It’s very similar to the Apollo program — which was a literal moonshot. A bunch of technologies were created along the way. Things like GPS, the fundamentals of the internet and semiconductors. All those were highly monetizable,”

Valuethemarkets.com, Digitonic Ltd (and our owners, directors, officers, managers, employees, affiliates, agents and assigns) are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above.

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

  • Kirsteen Mackay does not hold any position in the stock(s) and/or financial instrument(s) mentioned in the above article.
  • Kirsteen Mackay has not been paid to produce this piece by the company or companies mentioned above.

More News & Analysis

OYO IPO: what you need to know

Indian tech unicorn start-up OYO intends to issue new shares in animminent $1bn IPO. Is the Airbnb competitor a good investment opportunity?

Toast IPO: what you need to know

With a $30bn valuation, Toast made its co-founders instant billionairres at IPO. Is this a restaurant tech stock a good long-term growth investment?

Is Microsoft a good investment?

When it comes to tech stocks, few could ever hope to reach the level of Microsoft, but is it a good investment?